Obesity in Parkinson's disease patients on electrotherapy: collateral damage, adiposity rebound or secular trends?

Br J Nutr. 2005 Apr;93(4):417-9. doi: 10.1079/bjn20041337.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Body Mass Index
  • Brain / metabolism
  • Combined Modality Therapy
  • Dopamine / metabolism
  • Electric Stimulation Therapy / adverse effects*
  • Humans
  • Levodopa / therapeutic use
  • Malnutrition / metabolism
  • Obesity / complications*
  • Obesity / metabolism
  • Parkinson Disease / complications*
  • Parkinson Disease / metabolism
  • Parkinson Disease / therapy*
  • Receptors, Dopamine D2 / metabolism
  • Subthalamic Nucleus / surgery

Substances

  • Antiparkinson Agents
  • Receptors, Dopamine D2
  • Levodopa
  • Dopamine